Key result
CVD affects ~37% of US Hispanic women, with marked subpopulation heterogeneity challenging the Hispanic paradox.
Its licence doesn't allow us to show a copy here.
Why the study?
Hispanic women have a high burden of cardiovascular risk factors and adverse social determinants of health, and recent studies accounting for subpopulation diversity have challenged the reported lower rates of cardiovascular disease and mortality relative to non-Hispanic White women.
This review highlights that aggregate data masking the 'Hispanic paradox' obscure significant heterogeneity in cardiovascular risk factors, social determinants of health, and mortality across diverse Hispanic female subpopulations, necessitating culturally tailored and disaggregated approaches to cardiovascular care.
Disaggregated CVD assessment needed in Hispanic women; challenges the Hispanic paradox and leaves open tailored prevention research.
Cardiovascular disease affects 37% of Hispanic women and is the leading cause of death among Hispanic women in the United States. Hispanic women have a higher burden of cardiovascular risk factors, are disproportionally affected by social determinants of health, and face additional barriers related to immigration, such as discrimination, language proficiency, and acculturation. Despite this, Hispanic women show lower rates of cardiovascular disease and mortality compared with non-Hispanic White women. However, this "Hispanic paradox" is challenged by recent studies that account for the diversity in culture, race, genetic background, country of origin, and social determinants of health within Hispanic subpopulations. This review provides a comprehensive overview of the cardiovascular risk factors in Hispanic women, emphasizing the role of social determinants, and proposes a multipronged approach for equitable care.
No takes yet. Share an insight, caveat, or question.
Quesada et al. (2024) conducted a review in Cardiovascular disease in Hispanic women. Cardiovascular disease affects 37.3% of Hispanic women in the United States, with significant heterogeneity in risk factors and mortality across subpopulations that challenges the Hispanic paradox.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: